Michael Kane
Chief Executive Officer @MedPharm
Signup · Get unlimited contacts
WORK HISTORY
Chief Executive Officer @MedPharm
Durham, NC, US
MedPharm is a global topical and transdermal Contract Development and Manufacturing Organization (CDMO) with three sites in the US and UK. Focused on delivering a full suite of drug development and manufacturing services to innovators of all sizes focused on advancing topical and transepithelial pharmaceuticals. Formulation development, in vitro testing, clinical and commercial manufacturing within one integrated organization. Specialty capabilities also include the development and manufacture of hormone-based and highly potent drugs at the Company\'s GMP manufacturing facility in Durham, NC. Therapeutic areas include dermatology, women’s health, nasal, ophthalmic, and otic-> Portfolio company of Ampersand Capital Partners with meaningful investment from Great Point Partners and Bourne Partners-> Appointed CEO, MedPharm June 2024 as result of merger with Tergus Pharma, where I served as CEO from Oct 2022 to June 2024
EDUCATION
Indiana University of Pennsylvania
BS, Business Management
University of Notre Dame - Mendoza College of Business
MBA
SKILLS
ABOUT MICHAEL KANE
In my career, I have been influenced by a set of people and experiences that have provided me both depth and breadth. I have led and supported highly capable teams in accelerating results across the consumer health & wellness, pharmaceutical, food and beverage, and distribution sectors. These companies operate in manufacturing or value added distribution models in Asia, Canada and the United States. I have a passion for: Strategic Planning I Growth I Mergers & Acquisitions I People B2B I Performance Improvement I Strategic Partnerships
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.